Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Genet Mol Res ; 15(4)2016 Dec 02.
Article de Anglais | MEDLINE | ID: mdl-27966757

RÉSUMÉ

We assessed the effects of equine chorionic gonadotropin (eCG) on oocyte in vitro maturation (IVM), apoptosis, and follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR), and gonadotropin-releasing hormone receptor (GnRHR) expression and mRNA levels. Cumulus-oocyte complexes (COCs) were recovered from sheep ovaries and pooled in groups, before being cultured in IVM media containing varying eCG concentrations. Maturation and apoptosis rates were then calculated. Expression of FSHR, LHR, and GnRHR mRNA in oocytes was measured using quantitative reverse transcription polymerase chain reaction. Protein levels were ascertained by western blotting. Matured oocytes displayed and released an intact first polar body. Sheep oocyte maturation rates gradually increased as eCG concentration was raised from 0 to 20 µg/mL. Apoptosis rates of eCG-treated oocytes were lower than those of the control group, and were lowest using 20 µg/mL eCG. FSHR, LHR, and GnRHR mRNA expression increased (P < 0.01, P < 0.05, and P < 0.05, respectively, compared to 0 µg/mL eCG) with eCG concentration, being highest following exposure to 20 µg/mL. FSHR and GnRHR protein levels were significantly higher in oocytes administered 20 µg/mL eCG compared with those matured in the absence of eCG. eCG dose positively correlated with FSHR, LHR, and GnRHR mRNA and protein expression. In conclusion, eCG enhances maturation and decreases apoptosis of oocytes undergoing IVM, and heightens FSHR, LHR, and GnRHR expression. Such increased expression may facilitate oocyte IVM. These findings contribute to our understanding of the mechanisms of underlying hormonal control of sheep oocyte IVM, advancing ovine reproductive methods.


Sujet(s)
Gonadotrophine chorionique/pharmacologie , Gonadotrophine équine/pharmacologie , Ovocytes/effets des médicaments et des substances chimiques , Récepteur FSH/génétique , Récepteur LH/génétique , Animaux , Apoptose/effets des médicaments et des substances chimiques , Cellules cultivées , Relation dose-effet des médicaments , Femelle , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Equus caballus , Techniques de maturation in vitro des ovocytes/méthodes , Ovocytes/cytologie , Ovocytes/métabolisme , Récepteur FSH/métabolisme , Récepteur LH/métabolisme , Récepteurs à la gonadolibérine/génétique , Récepteurs à la gonadolibérine/métabolisme , Ovis
2.
Neuroscience ; 288: 187-99, 2015 Mar 12.
Article de Anglais | MEDLINE | ID: mdl-25559931

RÉSUMÉ

Monge's disease, also known as chronic mountain sickness (CMS), is a disease that potentially threatens more than 140 million highlanders during extended time living at high altitudes (over 2500m). The prevalence of CMS in Andeans is about 15-20%, suggesting that the majority of highlanders (non-CMS) are rather healthy at high altitudes; however, CMS subjects experience severe hypoxemia, erythrocytosis and many neurologic manifestations including migraine, headache, mental fatigue, confusion, and memory loss. The underlying mechanisms of CMS neuropathology are not well understood and no ideal treatment is available to prevent or cure CMS, except for phlebotomy. In the current study, we reprogrammed fibroblast cells from both CMS and non-CMS subjects' skin biopsies into the induced pluripotent stem cells (iPSCs), then differentiated into neurons and compared their neuronal properties. We discovered that CMS neurons were much less excitable (higher rheobase) than non-CMS neurons. This decreased excitability was not caused by differences in passive neuronal properties, but instead by a significantly lowered Na(+) channel current density and by a shift of the voltage-conductance curve in the depolarization direction. Our findings provide, for the first time, evidence of a neuronal abnormality in CMS subjects as compared to non-CMS subjects, hoping that such studies can pave the way to a better understanding of the neuropathology in CMS.


Sujet(s)
Mal de l'altitude/physiopathologie , Cellules souches pluripotentes induites/physiologie , Neurones/physiologie , Canaux sodiques/métabolisme , Potentiels d'action/physiologie , Adulte , Techniques de culture cellulaire , Cellules cultivées , Maladie chronique , Fibroblastes/cytologie , Fibroblastes/physiologie , Humains , Immunohistochimie , Cellules souches pluripotentes induites/cytologie , Mâle , Cellules souches neurales/cytologie , Cellules souches neurales/physiologie , Neurogenèse/physiologie , Neurones/cytologie , Techniques de patch-clamp , Pérou , Jeune adulte
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE